Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
149
datasets available to search
ShareScore release 0.9.0
Dataset results
149 results for “vascular growth”
PI3K-mediated crosstalk between angiopoietin and vascular endothelial growth factor C signaling pathways is required for lymphangiogenesis
GEO Series GSE202989. Mus musculus. 10 samples. Type: Expression profiling by high throughput sequencing.
Extrauterine growth restriction on pulmonary vascular endothelial dysfunction in adult male rats: the role of epigenetic mechanisms
GEO Series GSE48648. Rattus norvegicus. 6 samples. Type: Methylation profiling by genome tiling array.
RNA sequencing of pancreatic islet-derived beta cells, macrophages, and endothelial cells modulated by vascular endothelial growth factor-A signaling
GEO Series GSE163825. Mus musculus. 32 samples. Type: Expression profiling by high throughput sequencing.
Iodide Inhibits Vascular Endothelial Growth Factor-A Expression in Cultured Human Thyroid Follicles
GEO Series GSE12244. Homo sapiens. 2 samples. Type: Expression profiling by array.
RNA sequencing of pancreatic islets and islet-derived macrophages and endothelial cells modulated by vascular endothelial growth factor-A signaling
GEO Series GSE72546. Mus musculus. 12 samples. Type: Expression profiling by high throughput sequencing.
Inhibition of vascular growth by modulation of the AEA/FAAH axis
GEO Series GSE152552. Homo sapiens. 12 samples. Type: Expression profiling by array.
Resolving the design principles that control postnatal vascular growth and scaling
GEO Series GSE296391. Mus musculus. 4 samples. Type: Expression profiling by high throughput sequencing.
Genome-wide transcriptional alterations during vascular growth in skeletal muscles of type 2 diabetic mice in response to femoral artery ligation
GEO Series GSE69123. Mus musculus. 24 samples. Type: Expression profiling by high throughput sequencing.
Identification of HGF/c-MET as a biomarker of resistance to Vascular Endothelial Growth Factor Receptor (VEGFR) inhibitors
GEO Series GSE64472. Homo sapiens; Mus musculus. 22 samples. Type: Expression profiling by array.
Intracrine Vascular Endothelial Growth Factor Maintains Hippocampal Neural Stem Cell Quiescence
GEO Series GSE220871. Mus musculus. 2 samples. Type: Expression profiling by high throughput sequencing.
Data from: Neuropathy with vascular endothelial growth factor receptor tyrosine kinase inhibitors
Objective: To explore the association of peripheral neuropathy with vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) use in cancer patients. Methods: Published data search up to November 2018 reporting peripheral neuropathy in cancer patients treated with VEGFR-TKIs was performed. The primary outcome was presence of peripheral neuropathy at the end of the trial. Random-effects meta-analysis was performed to estimate Relative Risk (RR) of individual treatment. Results: Thirty Randomized Clinical Trials (RCTs) including 12,490 cancer patients were included in this analysis. Eight studies compared VEGFR-TKIs with placebo and the remaining studies compared VEGFR-TKIs with the standard chemotherapeutic regimen. When compared against placebo VEGFR-TKIs were associated with a higher risk of peripheral neuropathy (RR=1.76, 95% CI 1.13-2.75, p-value 0.01). Similarly, a stronger association was noted for sensory neuropathy with VEGFR-TKIs monotherapy (RR = 1.61; 95% CI 1.09-2.37, p = 0.02). Risk of peripheral neuropathy with VEGFR-TKIs was higher even when they were compared against control (either placebo or standard chemotherapeutic agents); RR=1.08, 95% CI 1.01-1.15, p-value 0.03. High-grade neuropathy (RR 1.28, 95% CI 1.06-1.54, p-value <0.01) and high-grade sensory neuropathy (RR 1.38, 95% CI 1.09-1.74, p-value <0.01) were noted more frequently with VEGFR-TKIs treatment compared against control. Conclusions: VEGFR-TKIs therapy appeared to be associated with an increased risk of neuropathy.
Ultrasound Monitoring of Fetuses With Vascular Intra-uterine Growth Restriction (IUGR) Using the Isthmus Systolic Index (ISI): Feasibility, Comparison to Normal Fetuses and Association With Perinatal
ClinicalTrials.gov study NCT02813525. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy
ClinicalTrials.gov study NCT02072408. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study
ClinicalTrials.gov study NCT03709381. IPD Sharing: NO. Countries: 1. Publications: 0.
Role of Vascular Endothelial Growth Factor (VEGF) in Acute Lung Injury/Adult Respiratory Distress Syndrome (ARDS)
ClinicalTrials.gov study NCT00319631. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Soluble Vascular Endothelial Growth Factor Receptor 2 as Predictor of Benefit From Bevacizumab Beyond Progression in Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT02623621. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy
ClinicalTrials.gov study NCT01310686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anterior and Posterior Segment Vascular Changes Following Laser and Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Diabetic Retinopathy
ClinicalTrials.gov study NCT01196325. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration
ClinicalTrials.gov study NCT01933152. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant
ClinicalTrials.gov study NCT05978622. IPD Sharing: UNDECIDED. Countries: 9. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.